Sanjay Singh (editor) - Emerging Trends in Nanomedicine

This Springer imprint is published by the registered company Springer Nature Singapore Pte Ltd.

The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore

Nanomedicine is an interdisciplinary science which involves the application of nanotechnology to health and medicine (Nezhadi et al. ).

Various nanostructures like polymeric nanoparticles, lipid-based nanoparticles, metal or metal oxide-based nanostructures, dendrimers, and carbon-based nanostructures have deep explored for the development of nanomedicines (Afzal et al. ). Lipid-based formulation Doxil was the first nanomedicine, approved by FDA in 1996. It is a liposomal formulation of doxorubicin and used for the treatment of various cancers. After that, various nanoformulations have been developed and many are under clinical trials. Nanomedicines can be administered to the patient via almost every route of drug administration. The most commonly used routes for nanomedicines are oral, intravenous, intraperitoneal, transdermal, and nasal routes.

The role of nanotechnology in various parts of medical field has been investigated. Different nanostructures have been used for bioimaging, drug and gene delivery, and as biosensors (Salata ). Metal or metal oxide-based nanostructures have also been explored for their nanozyme activities.

Bioimaging means visualizing or obtaining the functional images of living biological systems and is widely used in biomedical field (Erathodiyil and Ying ).